Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Hinton

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Science Translational Medicine|April 6, 2018
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
DICER1/Alu RNA dysmetabolism induces Caspase-8-mediated cell death in age-related macular degenerationYounghee Kim, Valeria Tarallo, Nagaraj Kerur, et al.
JCI Insight|August 18, 2017
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's diseaseYosef Koronyo, David Biggs, Ernesto Barron, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
ERK1/2 activation is a therapeutic target in age-related macular degenerationSami Dridi, Yoshio Hirano, Valeria Tarallo, et al.
Scientific Reports|March 19, 2021
Xeno-free cryopreservation of adherent retinal pigmented epithelium yields viable and functional cells in vitro and in vivoBritney O Pennington, Jeffrey K Bailey, Mohamed A Faynus, et al.
Science (New York, N.Y.)|November 22, 2014
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activityBenjamin J Fowler, Bradley D Gelfand, Younghee Kim, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Translational Vision Science & Technology|October 6, 2021
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
Stem Cell Reports|February 5, 2022
Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, David R Hinton, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Science Translational Medicine|April 6, 2018
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
DICER1/Alu RNA dysmetabolism induces Caspase-8-mediated cell death in age-related macular degenerationYounghee Kim, Valeria Tarallo, Nagaraj Kerur, et al.
JCI Insight|August 18, 2017
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's diseaseYosef Koronyo, David Biggs, Ernesto Barron, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
ERK1/2 activation is a therapeutic target in age-related macular degenerationSami Dridi, Yoshio Hirano, Valeria Tarallo, et al.
Scientific Reports|March 19, 2021
Xeno-free cryopreservation of adherent retinal pigmented epithelium yields viable and functional cells in vitro and in vivoBritney O Pennington, Jeffrey K Bailey, Mohamed A Faynus, et al.
Science (New York, N.Y.)|November 22, 2014
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activityBenjamin J Fowler, Bradley D Gelfand, Younghee Kim, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Translational Vision Science & Technology|October 6, 2021
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
Stem Cell Reports|February 5, 2022
Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, David R Hinton, et al.
Pageof 18